The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy
Articolo
Data di Pubblicazione:
2016
Citazione:
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy / P. Durando, S. Esposito, G. Bona, M. Cuccia, M.G. Desole, G. Ferrera, G. Gabutti, A. Pellegrino, F. Salvini, O. Henry, M. Povey, F. Marchetti. - In: VACCINE. - ISSN 0264-410X. - 34:36(2016 Aug 05), pp. 4278-4284. [10.1016/j.vaccine.2016.07.009]
Abstract:
Multiple vaccination visits and administrations can be stressful for infants, parents and healthcare providers. Multivalent combination vaccines can deliver the required number of antigens in fewer injections and clinic visits, while vaccine co-administration can also reduce the number of visits. This non-inferiority study was undertaken to evaluate the feasibility of co-administering a combined measles-mumps-rubella-varicella (MMRV) vaccine with conjugated meningococcal C (MenC) vaccine in a large cohort of healthy Italian toddlers.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Conjugated meningococcal C vaccine; Immunogenicity; Italy; Measles-mumps-rubella-varicella vaccine; Safety; Vaccination schedule
Elenco autori:
P. Durando, S. Esposito, G. Bona, M. Cuccia, M.G. Desole, G. Ferrera, G. Gabutti, A. Pellegrino, F. Salvini, O. Henry, M. Povey, F. Marchetti
Link alla scheda completa: